9 results on '"Gómez-Fernández, David"'
Search Results
2. A Multi-Target Pharmacological Correction of a Lipoyltransferase LIPT1 Gene Mutation in Patient-Derived Cellular Models.
- Author
-
Gómez-Fernández, David, Romero-González, Ana, Suárez-Rivero, Juan M., Cilleros-Holgado, Paula, Álvarez-Córdoba, Mónica, Piñero-Pérez, Rocío, Romero-Domínguez, José Manuel, Reche-López, Diana, López-Cabrera, Alejandra, Ibáñez-Mico, Salvador, Castro de Oliveira, Marta, Rodríguez-Sacristán, Andrés, González-Granero, Susana, García-Verdugo, José Manuel, and Sánchez-Alcázar, José A.
- Subjects
INBORN errors of metabolism ,WESTERN immunoblotting ,IRON overload ,BIOENERGETICS ,MUSCLE tone - Abstract
Mutations in the lipoyltransferase 1 (LIPT1) gene are rare inborn errors of metabolism leading to a fatal condition characterized by lipoylation defects of the 2-ketoacid dehydrogenase complexes causing early-onset seizures, psychomotor retardation, abnormal muscle tone, severe lactic acidosis, and increased urine lactate, ketoglutarate, and 2-oxoacid levels. In this article, we characterized the disease pathophysiology using fibroblasts and induced neurons derived from a patient bearing a compound heterozygous mutation in LIPT1. A Western blot analysis revealed a reduced expression of LIPT1 and absent expression of lipoylated pyruvate dehydrogenase E2 (PDH E2) and alpha-ketoglutarate dehydrogenase E2 (α-KGDH E2) subunits. Accordingly, activities of PDH and α-KGDH were markedly reduced, associated with cell bioenergetics failure, iron accumulation, and lipid peroxidation. In addition, using a pharmacological screening, we identified a cocktail of antioxidants and mitochondrial boosting agents consisting of pantothenate, nicotinamide, vitamin E, thiamine, biotin, and α-lipoic acid, which is capable of rescuing LIPT1 pathophysiology, increasing the LIPT1 expression and lipoylation of mitochondrial proteins, improving cell bioenergetics, and eliminating iron overload and lipid peroxidation. Furthermore, our data suggest that the beneficial effect of the treatment is mainly mediated by SIRT3 activation. In conclusion, we have identified a promising therapeutic approach for correcting LIPT1 mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Polydatin and Nicotinamide Rescue the Cellular Phenotype of Mitochondrial Diseases by Mitochondrial Unfolded Protein Response (mtUPR) Activation.
- Author
-
Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Pérez, Rocío, Romero Domínguez, José Manuel, Talaverón-Rey, Marta, Reche-López, Diana, Suárez-Rivero, Juan Miguel, Álvarez-Córdoba, Mónica, Romero-González, Ana, López-Cabrera, Alejandra, Oliveira, Marta Castro De, Rodríguez-Sacristan, Andrés, and Sánchez-Alcázar, José Antonio
- Subjects
- *
MITOCHONDRIAL DNA , *MITOCHONDRIAL proteins , *DENATURATION of proteins , *UNFOLDED protein response , *NICOTINAMIDE , *ELONGATION factors (Biochemistry) - Abstract
Primary mitochondrial diseases result from mutations in nuclear DNA (nDNA) or mitochondrial DNA (mtDNA) genes, encoding proteins crucial for mitochondrial structure or function. Given that few disease-specific therapies are available for mitochondrial diseases, novel treatments to reverse mitochondrial dysfunction are necessary. In this work, we explored new therapeutic options in mitochondrial diseases using fibroblasts and induced neurons derived from patients with mutations in the GFM1 gene. This gene encodes the essential mitochondrial translation elongation factor G1 involved in mitochondrial protein synthesis. Due to the severe mitochondrial defect, mutant GFM1 fibroblasts cannot survive in galactose medium, making them an ideal screening model to test the effectiveness of pharmacological compounds. We found that the combination of polydatin and nicotinamide enabled the survival of mutant GFM1 fibroblasts in stress medium. We also demonstrated that polydatin and nicotinamide upregulated the mitochondrial Unfolded Protein Response (mtUPR), especially the SIRT3 pathway. Activation of mtUPR partially restored mitochondrial protein synthesis and expression, as well as improved cellular bioenergetics. Furthermore, we confirmed the positive effect of the treatment in GFM1 mutant induced neurons obtained by direct reprogramming from patient fibroblasts. Overall, we provide compelling evidence that mtUPR activation is a promising therapeutic strategy for GFM1 mutations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Mitochondrial Quality Control via Mitochondrial Unfolded Protein Response (mtUPR) in Ageing and Neurodegenerative Diseases.
- Author
-
Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Pérez, Rocío, Romero-Domínguez, Jose Manuel, Reche-López, Diana, López-Cabrera, Alejandra, Álvarez-Córdoba, Mónica, Munuera-Cabeza, Manuel, Talaverón-Rey, Marta, Suárez-Carrillo, Alejandra, Romero-González, Ana, and Sánchez-Alcázar, Jose Antonio
- Subjects
- *
MITOCHONDRIAL proteins , *DENATURATION of proteins , *NEURODEGENERATION , *UNFOLDED protein response , *QUALITY control , *HUNTINGTIN protein - Abstract
Mitochondria play a key role in cellular functions, including energy production and oxidative stress regulation. For this reason, maintaining mitochondrial homeostasis and proteostasis (homeostasis of the proteome) is essential for cellular health. Therefore, there are different mitochondrial quality control mechanisms, such as mitochondrial biogenesis, mitochondrial dynamics, mitochondrial-derived vesicles (MDVs), mitophagy, or mitochondrial unfolded protein response (mtUPR). The last item is a stress response that occurs when stress is present within mitochondria and, especially, when the accumulation of unfolded and misfolded proteins in the mitochondrial matrix surpasses the folding capacity of the mitochondrion. In response to this, molecular chaperones and proteases as well as the mitochondrial antioxidant system are activated to restore mitochondrial proteostasis and cellular function. In disease contexts, mtUPR modulation holds therapeutic potential by mitigating mitochondrial dysfunction. In particular, in the case of neurodegenerative diseases, such as primary mitochondrial diseases, Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), Amyotrophic Lateral Sclerosis (ALS), or Friedreich's Ataxia (FA), there is a wealth of evidence demonstrating that the modulation of mtUPR helps to reduce neurodegeneration and its associated symptoms in various cellular and animal models. These findings underscore mtUPR's role as a promising therapeutic target in combating these devastating disorders. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Actin Polymerization Defects Induce Mitochondrial Dysfunction in Cellular Models of Nemaline Myopathies.
- Author
-
Piñero-Pérez, Rocío, López-Cabrera, Alejandra, Álvarez-Córdoba, Mónica, Cilleros-Holgado, Paula, Talaverón-Rey, Marta, Suárez-Carrillo, Alejandra, Munuera-Cabeza, Manuel, Gómez-Fernández, David, Reche-López, Diana, Romero-González, Ana, Romero-Domínguez, José Manuel, de Pablos, Rocío M., and Sánchez-Alcázar, José A.
- Subjects
NEMALINE myopathy ,MUSCLE weakness ,MITOCHONDRIA ,MUSCLE hypotonia ,LINOLEIC acid ,FLUORESCENCE microscopy ,POLYMERIZATION - Abstract
Nemaline myopathy (NM) is one of the most common forms of congenital myopathy and it is identified by the presence of "nemaline bodies" (rods) in muscle fibers by histopathological examination. The most common forms of NM are caused by mutations in the Actin Alpha 1 (ACTA1) and Nebulin (NEB) genes. Clinical features include hypotonia and muscle weakness. Unfortunately, there is no curative treatment and the pathogenetic mechanisms remain unclear. In this manuscript, we examined the pathophysiological alterations in NM using dermal fibroblasts derived from patients with mutations in ACTA1 and NEB genes. Patients' fibroblasts were stained with rhodamine–phalloidin to analyze the polymerization of actin filaments by fluorescence microscopy. We found that patients' fibroblasts showed incorrect actin filament polymerization compared to control fibroblasts. Actin filament polymerization defects were associated with mitochondrial dysfunction. Furthermore, we identified two mitochondrial-boosting compounds, linoleic acid (LA) and L-carnitine (LCAR), that improved the formation of actin filaments in mutant fibroblasts and corrected mitochondrial bioenergetics. Our results indicate that cellular models can be useful to study the pathophysiological mechanisms involved in NM and to find new potential therapies. Furthermore, targeting mitochondrial dysfunction with LA and LCAR can revert the pathological alterations in NM cellular models. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Antioxidants Prevent Iron Accumulation and Lipid Peroxidation, but Do Not Correct Autophagy Dysfunction or Mitochondrial Bioenergetics in Cellular Models of BPAN.
- Author
-
Suárez-Carrillo, Alejandra, Álvarez-Córdoba, Mónica, Romero-González, Ana, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Cilleros-Holgado, Paula, Piñero-Pérez, Rocío, Reche-López, Diana, Gómez-Fernández, David, Romero-Domínguez, José Manuel, Munuera-Cabeza, Manuel, Díaz, Antonio, González-Granero, Susana, García-Verdugo, José Manuel, and Sánchez-Alcázar, José A.
- Subjects
BIOENERGETICS ,AUTOPHAGY ,MITOCHONDRIA ,BASAL ganglia ,IRON ,LIPIDS ,QUORUM sensing - Abstract
Neurodegeneration with brain iron accumulation (NBIA) is a group of rare neurogenetic disorders frequently associated with iron accumulation in the basal nuclei of the brain. Among NBIA subtypes, β-propeller protein-associated neurodegeneration (BPAN) is associated with mutations in the autophagy gene WDR45. The aim of this study was to demonstrate the autophagic defects and secondary pathological consequences in cellular models derived from two patients harboring WDR45 mutations. Both protein and mRNA expression levels of WDR45 were decreased in patient-derived fibroblasts. In addition, the increase of LC3B upon treatments with autophagy inducers or inhibitors was lower in mutant cells compared to control cells, suggesting decreased autophagosome formation and impaired autophagic flux. A transmission electron microscopy (TEM) analysis showed mitochondrial vacuolization associated with the accumulation of lipofuscin-like aggregates containing undegraded material. Autophagy dysregulation was also associated with iron accumulation and lipid peroxidation. In addition, mutant fibroblasts showed altered mitochondrial bioenergetics. Antioxidants such as pantothenate, vitamin E and α-lipoic prevented lipid peroxidation and iron accumulation. However, antioxidants were not able to correct the expression levels of WDR45, neither the autophagy defect nor cell bioenergetics. Our study demonstrated that WDR45 mutations in BPAN cellular models impaired autophagy, iron metabolism and cell bioenergetics. Antioxidants partially improved cell physiopathology; however, autophagy and cell bioenergetics remained affected. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration.
- Author
-
Álvarez-Córdoba, Mónica, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Pérez, Rocío, Reche-López, Diana, Munuera-Cabeza, Manuel, Suárez-Carrillo, Alejandra, Romero-González, Ana, Romero-Domínguez, Jose Manuel, López-Cabrera, Alejandra, Armengol, José Ángel, and Sánchez-Alcázar, José Antonio
- Subjects
INDIVIDUALIZED medicine ,NEURODEGENERATION ,VITAMIN E ,IRON ores ,VITAMIN B1 ,IRON overload ,THIAMIN pyrophosphate - Abstract
The term neurodegeneration with brain iron accumulation (NBIA) brings together a broad set of progressive and disabling neurological genetic disorders in which iron is deposited preferentially in certain areas of the brain. Among NBIA disorders, the most frequent subtype is pantothenate kinase-associated neurodegeneration (PKAN) caused by pathologic variants in the PANK2 gene codifying the enzyme pantothenate kinase 2 (PANK2). To date, there are no effective treatments to stop the progression of these diseases. This review discusses the utility of patient-derived cell models as a valuable tool for the identification of pharmacological or natural compounds for implementing polytarget precision medicine in PKAN. Recently, several studies have described that PKAN patient-derived fibroblasts present the main pathological features associated with the disease including intracellular iron overload. Interestingly, treatment of mutant cell cultures with various supplements such as pantothenate, pantethine, vitamin E, omega 3, α-lipoic acid L-carnitine or thiamine, improved all pathophysiological alterations in PKAN fibroblasts with residual expression of the PANK2 enzyme. The information provided by pharmacological screenings in patient-derived cellular models can help optimize therapeutic strategies in individual PKAN patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Neurodegeneration, Mitochondria, and Antibiotics.
- Author
-
Suárez-Rivero, Juan M., López-Pérez, Juan, Muela-Zarzuela, Inés, Pastor-Maldonado, Carmen, Cilleros-Holgado, Paula, Gómez-Fernández, David, Álvarez-Córdoba, Mónica, Munuera-Cabeza, Manuel, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Suárez-Carrillo, Alejandra, Piñero-Pérez, Rocío, Reche-López, Diana, Romero-Domínguez, José M., and Sánchez-Alcázar, José Antonio
- Subjects
PERIPHERAL nervous system ,NEURODEGENERATION ,MITOCHONDRIA ,ANTIBIOTICS ,ANTI-infective agents - Abstract
Neurodegenerative diseases are characterized by the progressive loss of neurons, synapses, dendrites, and myelin in the central and/or peripheral nervous system. Actual therapeutic options for patients are scarce and merely palliative. Although they affect millions of patients worldwide, the molecular mechanisms underlying these conditions remain unclear. Mitochondrial dysfunction is generally found in neurodegenerative diseases and is believed to be involved in the pathomechanisms of these disorders. Therefore, therapies aiming to improve mitochondrial function are promising approaches for neurodegeneration. Although mitochondrial-targeted treatments are limited, new research findings have unraveled the therapeutic potential of several groups of antibiotics. These drugs possess pleiotropic effects beyond their anti-microbial activity, such as anti-inflammatory or mitochondrial enhancer function. In this review, we will discuss the controversial use of antibiotics as potential therapies in neurodegenerative diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases.
- Author
-
Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Pérez, Rocío, Reche-López, Diana, Álvarez-Córdoba, Mónica, Munuera-Cabeza, Manuel, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Suárez-Carrillo, Alejandra, Romero-González, Ana, Suárez-Rivero, Juan Miguel, Romero-Domínguez, Jose Manuel, and Sánchez-Alcázar, Jose Antonio
- Subjects
- *
HOMEOSTASIS , *UNFOLDED protein response , *MITOCHONDRIAL DNA , *MITOCHONDRIA , *CELL survival , *REACTIVE oxygen species - Abstract
Mitochondrial dysfunction is a key pathological event in many diseases. Its role in energy production, calcium homeostasis, apoptosis regulation, and reactive oxygen species (ROS) balance render mitochondria essential for cell survival and fitness. However, there are no effective treatments for most primary and secondary mitochondrial diseases to this day. Therefore, new therapeutic approaches, such as the modulation of the mitochondrial unfolded protein response (mtUPR), are being explored. mtUPRs englobe several compensatory processes related to proteostasis and antioxidant system mechanisms. mtUPR activation, through an overcompensation for mild intracellular stress, promotes cell homeostasis and improves lifespan and disease alterations in biological models of mitochondrial dysfunction in age-related diseases, cardiopathies, metabolic disorders, and primary mitochondrial diseases. Although mtUPR activation is a promising therapeutic option for many pathological conditions, its activation could promote tumor progression in cancer patients, and its overactivation could lead to non-desired side effects, such as the increased heteroplasmy of mitochondrial DNA mutations. In this review, we present the most recent data about mtUPR modulation as a therapeutic approach, its role in diseases, and its potential negative consequences in specific pathological situations. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.